PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)

Conditions: Rheumatoid Arthritis Interventions: Other: Lab Collection Only Sponsors: Scipher Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials